Besides developmental delay and intellectual disability, most patients carrying AFF3 variants presented with encephalopathy, skeletal dysplasia, failure to thrive, microcephaly and global brain atrophy (Steichen-Gersdorf et al., 2008; Shimizu et al., 2019; Voisin et al., 2021). This evidence concerns the gene AFF3 and Intellectual disability.